X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Panacea Biotec Ltd.
BSE CODE: 531349   |   NSE CODE: PANACEABIO   |   ISIN CODE : INE922B01023   |   16-Dec-2025 14:53 Hrs IST
BSE NSE
Rs. 350.90
-6.45 ( -1.8% )
 
Prev Close ( Rs.)
357.35
Open ( Rs.)
358.00
 
High ( Rs.)
358.00
Low ( Rs.)
350.90
 
Volume
1554
Week Avg.Volume
6799
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 352.00
-5.15 ( -1.44% )
 
Prev Close ( Rs.)
357.15
Open ( Rs.)
358.20
 
High ( Rs.)
358.35
Low ( Rs.)
351.05
 
Volume
10500
Week Avg.Volume
128126
 
52 WK High-Low Range(Rs.)
281.1
581.9
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)-2.49  0.58  -14.29  -15.28  -2.35  
   CEPS(Rs)0.83  4.02  -10.29  -10.96  1.98  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)51.26  53.74  53.17  67.77  82.97  
   Tax Rate(%)41.56  15.60  -39.51  0.00  -12.15  
Margin Ratios          
   Core EBITDA Margin(%)-2.23  3.93  -24.21  -30.75  0.14  
   EBIT Margin(%)-3.40  4.99  -20.36  -36.62  -1.53  
   Pre Tax Margin(%)-8.37  1.17  -24.25  -39.60  -3.69  
   PAT Margin (%)-4.89  0.98  -33.84  -39.60  -4.14  
   Cash Profit Margin (%)1.62  6.84  -24.37  -28.41  3.49  
Performance Ratios          
   ROA(%)-1.69  0.39  -9.57  -9.88  -1.27  
   ROE(%)-4.74  1.08  -23.64  -20.27  -2.11  
   ROCE(%)-2.13  4.08  -11.36  -16.14  -0.70  
   Asset Turnover(x)0.34  0.40  0.28  0.25  0.31  
   Sales/Fixed Asset(x)0.37  0.43  0.30  0.28  0.41  
   Working Capital/Sales(x)-5.40  -5.49  -5.00  50.58  5.99  
Efficiency Ratios          
   Fixed Capital/Sales(x)2.67  2.33  3.32  3.58  2.43  
   Receivable days18.71  11.82  25.11  45.26  27.77  
   Inventory Days152.40  113.44  173.06  167.03  97.64  
   Payable days499.26  315.92  306.74  437.99  269.16  
Valuation Parameters          
   PER(x)0.00  209.28  0.00  0.00  0.00  
   PCE(x)533.61  30.16  -10.53  -13.52  89.37  
   Price/Book(x)8.60  2.26  2.04  2.19  2.14  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)9.25  2.38  2.81  4.03  3.09  
   EV/Core EBITDA(x)295.78  21.90  -25.64  -15.80  50.04  
   EV/EBIT(x)-270.36  47.58  -13.72  -10.97  -199.19  
   EV/CE(x)5.28  1.89  1.69  1.02  1.10  
   M Cap / Sales8.71  2.07  2.58  3.86  3.16  
Growth Ratio          
   Net Sales Growth(%)-13.83  39.89  9.16  -31.45  -29.84  
   Core EBITDA Growth(%)-75.21  238.60  53.09  -383.02  -60.64  
   EBIT Growth(%)-158.92  134.14  39.11  -1521.99  -147.32  
   PAT Growth(%)-528.93  104.06  6.45  -549.25  90.58  
   EPS Growth(%)-528.92  104.06  6.45  -549.25  90.58  
Financial Stability Ratios          
   Total Debt/Equity(x)0.73  0.38  0.31  0.20  0.13  
   Current Ratio(x)0.84  0.74  0.79  1.02  1.29  
   Quick Ratio(x)0.40  0.30  0.33  0.49  0.85  
   Interest Cover(x)-0.69  1.31  -5.24  -12.29  -0.71  
   Total Debt/Mcap(x)0.08  0.17  0.15  0.09  0.06